Skip to main content
Top
Published in: Journal of Cancer Education 2/2020

01-04-2020 | Sarcoma

Importance of and Satisfaction with Information about Their Disease in Cancer Patients

Authors: Hannah Eisfeld, Fabienne Bauer, Clara Dubois, Thorsten Schmidt, Karin Kastrati, Andreas Hochhaus, Jutta Hübner

Published in: Journal of Cancer Education | Issue 2/2020

Login to get access

Abstract

To learn more about information needs and satisfaction with provided information among cancer patients and whether dissatisfaction with information has any association with how therapy decisions are made. An online survey was conducted during March 2015 and January 2016 by the German non-profit patient organization “Das Lebenshaus e.V.” among their members with rare solid tumors. A total of 338 records was analyzed. The majority found information on their disease important and was satisfied with the provided information. The participants were less satisfied with the information concerning management of side effects than with other aspects of information (p < .001). Support groups, lectures, and the oncologist were rated as the most helpful sources of information followed by a second opinion and media. Participants who were dissatisfied with the information more often made the decision on the treatment alone by themselves (p < .001). Our results show a high satisfaction with disease-related information among our study participants. Improvements could be made by offering more information on the management of side effects and by giving more information about support groups, reliable websites, and other helpful media.
Literature
3.
go back to reference Mesters I, van den Borne B, De Boer M, Pruyn J (2001) Measuring information needs among cancer patients. Patient Educ Couns 43:253–262CrossRef Mesters I, van den Borne B, De Boer M, Pruyn J (2001) Measuring information needs among cancer patients. Patient Educ Couns 43:253–262CrossRef
9.
go back to reference Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MHN (2007) A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag 34:81–93. https://doi.org/10.1016/j.jpainsymman.2006.09.035 CrossRef Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall MHN (2007) A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag 34:81–93. https://​doi.​org/​10.​1016/​j.​jpainsymman.​2006.​09.​035 CrossRef
15.
go back to reference Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB (1988) Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med 27:1139–1145CrossRef Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB (1988) Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med 27:1139–1145CrossRef
20.
go back to reference Rietveld MJA, Husson O, Vos MCC, van de Poll-Franse LV, Ottevanger PBN, Ezendam NPM (2018) Association between information provision and supportive care needs among ovarian cancer survivors: a cross-sectional study from the PROFILES registry. Psychooncology 27:1922–1929. https://doi.org/10.1002/pon.4742 CrossRefPubMed Rietveld MJA, Husson O, Vos MCC, van de Poll-Franse LV, Ottevanger PBN, Ezendam NPM (2018) Association between information provision and supportive care needs among ovarian cancer survivors: a cross-sectional study from the PROFILES registry. Psychooncology 27:1922–1929. https://​doi.​org/​10.​1002/​pon.​4742 CrossRefPubMed
21.
26.
go back to reference Kim AR, Park H-A (2015) Web-based self-management support interventions for cancer survivors: a systematic review and meta-analyses. Stud Health Technol Inform 216:142–147PubMed Kim AR, Park H-A (2015) Web-based self-management support interventions for cancer survivors: a systematic review and meta-analyses. Stud Health Technol Inform 216:142–147PubMed
28.
go back to reference Nayir E, Tanriverdi O, Karakas Y et al (2016) Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) study. J BUON 21:714–719PubMed Nayir E, Tanriverdi O, Karakas Y et al (2016) Tendency of cancer patients and their relatives to use internet for health-related searches: Turkish Oncology Group (TOG) study. J BUON 21:714–719PubMed
40.
go back to reference Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F (2014) Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes. Ann Oncol 25:447–454. https://doi.org/10.1093/annonc/mdt557 CrossRefPubMed Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F (2014) Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes. Ann Oncol 25:447–454. https://​doi.​org/​10.​1093/​annonc/​mdt557 CrossRefPubMed
Metadata
Title
Importance of and Satisfaction with Information about Their Disease in Cancer Patients
Authors
Hannah Eisfeld
Fabienne Bauer
Clara Dubois
Thorsten Schmidt
Karin Kastrati
Andreas Hochhaus
Jutta Hübner
Publication date
01-04-2020
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 2/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-1480-7

Other articles of this Issue 2/2020

Journal of Cancer Education 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine